Takeda acquires Millennium

When I profiled Millennium Pharmaceuticals' chief scientific officer, Joe Bolen, in last month's issue of __The Scientist,__ he described some amusing airport foibles that had taken place during a linkurl:recent trip to Japan.;http://www.the-scientist.com/article/display/54340/ Now the whole company is going to Japan - at least on paper. Today, Millennium Pharmaceuticals, one of the first genomics companies in the US, was linkurl:acquired;http://investor.millennium.com/phoenix.zhtml?c=80159&p=ir

By | April 10, 2008

When I profiled Millennium Pharmaceuticals' chief scientific officer, Joe Bolen, in last month's issue of __The Scientist,__ he described some amusing airport foibles that had taken place during a linkurl:recent trip to Japan.;http://www.the-scientist.com/article/display/54340/ Now the whole company is going to Japan - at least on paper. Today, Millennium Pharmaceuticals, one of the first genomics companies in the US, was linkurl:acquired;http://investor.millennium.com/phoenix.zhtml?c=80159&p=irol-newsArticle&ID=1127852&highlight= by Takeda Pharmaceuticals, Japan's largest pharma company, for a whopping $8.8 billion dollars. Although Millennium will become a wholly owned subsidiary, the company will continue its operations in Cambridge Massachusetts.
Advertisement

Popular Now

  1. NYU Halts Studies, Suspends Investigator
    The Nutshell NYU Halts Studies, Suspends Investigator

    Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.

  2. Exercise-Induced Muscle Factor Promotes Memory
  3. The Meaning of Pupil Dilation
    Daily News The Meaning of Pupil Dilation

    Scientists are using pupil measurements to study a wide range of psychological processes and to get a glimpse into the mind.

  4. Brexit’s Effects on Science